Traws Pharma Inc. (TRAW)

NASDAQ: TRAW · Real-Time Price · USD

1.44

-0.01 (-0.69%)

At close: May 01, 2025, 3:59 PM

1.45

0.69%

Pre-market: May 02, 2025, 07:01 AM EDT

Traws Pharma Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	226K	226K	226K	226K	231K	2.18M	1.23M	787K	5.55M
Cost of Revenue	12K	16K	14K	14K	n/a	n/a	n/a	n/a	n/a
Gross Profit	214K	210K	212K	212K	231K	2.18M	1.23M	787K	5.55M
Operating Income	-142.37M	-20.3M	-19.63M	-16.5M	-24.99M	-21.7M	-23.28M	-25.74M	-23.7M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-166.52M	-18.95M	-18.96M	-16.16M	-25.15M	-21.49M	-20.53M	-24.08M	-19.65M
Net Income	-166.52M	-18.95M	-18.96M	-16.16M	-25.16M	-21.5M	-20.57M	-24.09M	-19.67M
Selling & General & Admin	12.29M	9.09M	8.45M	9.43M	8.33M	8.35M	7.59M	7.41M	9.08M
Research & Development	12.85M	11.41M	11.41M	7.3M	16.9M	15.52M	16.87M	19.03M	20.07M
Other Expenses	117.46M	n/a	663K	12K	48K	n/a	n/a	n/a	n/a
Operating Expenses	142.6M	20.51M	19.85M	16.72M	25.22M	23.87M	24.45M	26.44M	29.15M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	142.6M	20.52M	19.85M	16.72M	25.22M	23.88M	24.51M	26.52M	29.25M
Income Tax Expense	n/a	n/a	-214.49K	-321K	4K	10K	-124K	13K	14K
Shares Outstanding (Basic)	1.55M	20.99M	20.91M	16.83M	11.6M	958.97K	274.94K	40K	19.67K
Shares Outstanding (Diluted)	1.55M	839.55K	20.91M	16.83M	11.6M	958.97K	274.94K	40K	19.67K
EPS (Basic)	-35.21	-0.9	-0.91	-0.96	-2.17	-22.42	-74.83	-602.28	-999.7
EPS (Diluted)	-35.21	-22.57	-0.91	-0.96	-2.17	-22.42	-74.83	-602.28	-999.7
EBITDA	-24.9M	-20.28M	-19.61M	-16.48M	-24.98M	-21.68M	-23.23M	-25.65M	-23.61M
EBIT	-24.91M	-20.3M	-19.63M	-16.5M	-24.99M	-21.7M	-23.28M	-25.74M	-23.7M
Depreciation & Amortization	12K	16K	14K	14K	13K	14K	55K	88K	96K